Asset vs asset
Hyperliquid is a exchange-linked market proxy with $9.39B in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | Hyperliquid | Injective |
|---|---|---|
| Market role | exchange-linked market proxy | INJ market beta asset |
| Price | $39.37 | $3.03 |
| Market cap | $9.39B | $303.19M |
| 24h volume | $267.37M | $38.31M |
| 7d change | -4.80% | -1.11% |
| Relative size | Hyperliquid is 30.96x Injective's market cap | Injective is 0.03x Hyperliquid's market cap |
| Volume comparison | Hyperliquid trades at 6.98x Injective's 24h volume | Injective trades at 0.14x Hyperliquid's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets